X

Health Care

J B Chemicals & Pharmaceuticals Ltd Q3FY25; 21% rise in Profits

J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with…

Ipca Laboratories Ltd Q3FY25; 25% rise in Profits

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q3FY25…

Narayana Hrudayalaya Ltd Q3FY25; 3% rise in Profits

Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals…

Metropolis Healthcare Ltd Q3FY25; 15% rise in Profits

Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across…

Max Healthcare Institute Ltd Q3FY25; 17% fall in Profits

Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical…

Mankind Pharma Ltd Q3FY25; 15% fall in Profits

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and…

ZYDUSLIFE Q3 2024-2025 Call Highlights: Profit Jump, Robust Margins & Expansion Plans!

Zydus Lifesciences Ltd., a leading Indian Pharmaceutical company, in its Q3 earnings call discussed strong performance across multiple segments, with…

DIVISLAB Q3 2024-2025 Call Highlights: Expansion Plans, Generics Growth, and API Challenges!

Divi's Laboratories Ltd., an Indian multinational pharmaceutical company that manufactures and exports API's, Intermediates and Nutraceutical ingredients, in its Q3…

Lupin Ltd Q3FY25; 39% rise in Profits

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and…

SUNPHARMA Q3 2024-2025 Call Highlights: India Leads, US Slows, Specialty Expands!

Sun Pharmaceutical Industries Ltd., the fourth largest specialty generic pharmaceutical company in the world, in its Q3 earnings call discussed…